Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
Titel:
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
Auteur:
Dent, Rebecca A Lindeman, Geoffrey J Clemons, Mark Wildiers, Hans Chan, Arlene McCarthy, Nicole J Singer, Christian F Lowe, Elizabeth S Watkins, Claire L Carmichael, James